Cargando…

Effect of common genetic variants on the risk of cirrhosis in non‐alcoholic fatty liver disease during 20 years of follow‐up

BACKGROUND AND AIMS: Several genotypes associate with a worse histopathological profile in patients with non‐alcoholic fatty liver disease (NAFLD). Whether genotypes impact long‐term outcomes is unclear. We investigated the importance of PNPLA3, TM6SF2, MBOAT7 and GCKR genotype for the development o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holmer, Magnus, Ekstedt, Mattias, Nasr, Patrik, Zenlander, Robin, Wester, Axel, Tavaglione, Federica, Romeo, Stefano, Kechagias, Stergios, Stål, Per, Hagström, Hannes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Genetics and Rare Liver Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828463/ https://www.ncbi.nlm.nih.gov/pubmed/36166317 http://dx.doi.org/10.1111/liv.15438

Ejemplares similares

Repeated measurements of non‐invasive fibrosis tests to monitor the progression of non‐alcoholic fatty liver disease: A long‐term follow‐up study
por: Balkhed, Wile, et al.
Publicado: (2022)

Natural History of NAFLD/NASH
por: Ekstedt, Mattias, et al.
Publicado: (2017)

Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long‐term follow‐up study
por: Hagström, Hannes, et al.
Publicado: (2017)

Non-alcoholic fatty liver disease does not increase dementia risk although histology data might improve risk prediction
por: Shang, Ying, et al.
Publicado: (2020)

Development of Serum Marker Models to Increase Diagnostic Accuracy of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: The New LINKI Algorithm Compared with Established Algorithms
por: Lykiardopoulos, Byron, et al.
Publicado: (2016)

Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease
por: Paternostro, Rafael, et al.
Publicado: (2020)

Time trends in mortality and life expectancy in 22,658 patients hospitalized with alcohol-associated cirrhosis: A nationwide cohort study
por: Wester, Axel, et al.
Publicado: (2023)

Natural history of nonalcoholic fatty liver disease: A prospective follow‐up study with serial biopsies
por: Nasr, Patrik, et al.
Publicado: (2017)

Non-invasive diagnosis and staging of non-alcoholic fatty liver disease
por: Kechagias, Stergios, et al.
Publicado: (2022)

Moderate alcohol consumption is associated with significant fibrosis progression in NAFLD
por: Blomdahl, Julia, et al.
Publicado: (2023)

The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver disease
por: Scheiner, Bernhard, et al.
Publicado: (2020)

Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension
por: Scheiner, Bernhard, et al.
Publicado: (2019)

Reply to: “Reduced steatosis and weight as a result of specific diets or the dietitian themselves”
por: Holmer, Magnus, et al.
Publicado: (2021)

Sebelipase alfa for lysosomal acid lipase deficiency: 5‐year treatment experience from a phase 2 open‐label extension study
por: Malinová, Vĕra, et al.
Publicado: (2020)

Choledochal malformations in adults in the Netherlands: Results from a nationwide retrospective cohort study
por: de Kleine, Ruben H., et al.
Publicado: (2020)

Genetic variant rs72613567 of HSD17B13 gene reduces alcohol‐related liver disease risk in Chinese Han population
por: Chen, Haizhen, et al.
Publicado: (2020)

Reduced iron export associated with hepcidin resistance can explain the iron overload spectrum in ferroportin disease
por: Viveiros, André, et al.
Publicado: (2020)

Genetic variants of innate immunity receptors are associated with mortality in cirrhotic patients with bacterial infection
por: Schaapman, Jelte J., et al.
Publicado: (2020)

PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus‐related diseases
por: De Re, Valli, et al.
Publicado: (2020)

Prolonged exposure to welding fumes as a novel cause of systemic iron overload
por: Mariani, Raffaella, et al.
Publicado: (2021)

Exome sequencing in patient‐parent trios suggests new candidate genes for early‐onset primary sclerosing cholangitis
por: Haisma, Sjoukje‐Marije, et al.
Publicado: (2021)

Liver pathology and biochemistry in patients with mutations in TRIM37 gene (Mulibrey nanism)
por: Sivunen, Johanna, et al.
Publicado: (2022)

A minority of somatically mutated genes in pre‐existing fatty liver disease have prognostic importance in the development of NAFLD
por: Mann, Jake P., et al.
Publicado: (2022)

Clinical characterization of NTCP deficiency in paediatric patients : A case‐control study based on SLC10A1 genotyping analysis
por: Deng, Li‐Jing, et al.
Publicado: (2021)

Efficacy and safety of givosiran for acute hepatic porphyria: 24‐month interim analysis of the randomized phase 3 ENVISION study
por: Ventura, Paolo, et al.
Publicado: (2021)

Abdominal wall hernia is a frequent complication of polycystic liver disease and associated with hepatomegaly
por: Barten, Thijs R. M., et al.
Publicado: (2022)

Long‐term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia
por: Larrey, Dominique, et al.
Publicado: (2022)

Histologic regression of fibrillary glomerulonephritis: the first report of biopsy-proven spontaneous resolution of disease
por: Sekulic, Miroslav, et al.
Publicado: (2017)

Risk of hepatic and extrahepatic cancer in NAFLD: A population‐based cohort study
por: Björkström, Karl, et al.
Publicado: (2022)

Acute kidney injury is independently associated with death in patients with cirrhosis
por: Scott, Robert A, et al.
Publicado: (2013)

Patient understanding of liver cirrhosis and improvement using multimedia education
por: Goldsworthy, Matthew A, et al.
Publicado: (2017)

Improved outcomes following the implementation of a decompensated cirrhosis discharge bundle
por: Smethurst, Katherine, et al.
Publicado: (2021)

Global strategy for the diagnosis and management of acute kidney injury in patients with liver cirrhosis
por: Sanchez, Lukas Otero, et al.
Publicado: (2021)

Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020
por: Horhat, Adelina, et al.
Publicado: (2021)

Deprescribing medications that may increase the risk of hepatic encephalopathy: A qualitative study of patients with cirrhosis and their doctors
por: Williams, Sydni, et al.
Publicado: (2021)

Neutrophil extracellular traps in patients with liver cirrhosis and hepatocellular carcinoma
por: Zenlander, Robin, et al.
Publicado: (2021)

Response to the NCEPOD report: development of a care bundle for patients admitted with decompensated cirrhosis—the first 24 h
por: McPherson, Stuart, et al.
Publicado: (2016)

Cost-effectiveness analysis of noninvasive tests to identify advanced fibrosis in non-alcoholic fatty liver disease
por: Gruneau, Lina, et al.
Publicado: (2023)

Persistent severe polyuria after renal transplant
por: Wong, Timothy, et al.
Publicado: (2016)

Outcome in patients with idiopathic retroperitoneal fibrosis treated with corticosteroid or tamoxifen monotherapy
por: van der Bilt, Floor E., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rm6lqvsfuj4stvb2o5id2qdk1s